Cargando…
A smartphone application for treating depressive symptoms: study protocol for a randomised controlled trial
BACKGROUND: Depression is a commonly occurring disorder linked to diminished role functioning and quality of life. The development of treatments that overcome barriers to accessing treatment remains an important area of clinical research as most people delay or do not receive treatment at an appropr...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984798/ https://www.ncbi.nlm.nih.gov/pubmed/29859060 http://dx.doi.org/10.1186/s12888-018-1752-5 |
_version_ | 1783328667336704000 |
---|---|
author | Deady, M. Johnston, D. A. Glozier, N. Milne, D. Choi, I. Mackinnon, A. Mykletun, A. Calvo, R. A. Gayed, A. Bryant, R. Christensen, H. Harvey, S. B. |
author_facet | Deady, M. Johnston, D. A. Glozier, N. Milne, D. Choi, I. Mackinnon, A. Mykletun, A. Calvo, R. A. Gayed, A. Bryant, R. Christensen, H. Harvey, S. B. |
author_sort | Deady, M. |
collection | PubMed |
description | BACKGROUND: Depression is a commonly occurring disorder linked to diminished role functioning and quality of life. The development of treatments that overcome barriers to accessing treatment remains an important area of clinical research as most people delay or do not receive treatment at an appropriate time. The workplace is an ideal setting to roll-out an intervention, particularly given the substantial psychological benefits associated with remaining in the workforce. Mobile health (mhealth) interventions utilising smartphone applications (apps) offer novel solutions to disseminating evidence based programs, however few apps have undergone rigorous testing. The present study aims to evaluate the effectiveness of a smartphone app designed to treat depressive symptoms in workers. METHODS: The present study is a multicentre randomised controlled trial (RCT), comparing the effectiveness of the intervention to that of an attention control. The primary outcome measured will be reduced depressive symptoms at 3 months. Secondary outcomes such as wellbeing and work performance will also be measured. Employees from a range of industries will be recruited via a mixture of targeted social media advertising and Industry partners. Participants will be included if they present with likely current depression at baseline. Following baseline assessment (administered within the app), participants will be randomised to receive one of two versions of the Headgear application: 1) Intervention (a 30-day mental health intervention focusing on behavioural activation and mindfulness), or 2) attention control app (mood monitoring for 30 days). Participants will be blinded to their allocation. Analyses will be conducted within an intention to treat framework using mixed modelling. DISCUSSION: The results of this trial will provide valuable information about the effectiveness of mhealth interventions in the treatment of depressive symptoms in a workplace context. TRIAL REGISTRATION: The current trial is registered with the Australian and New Zealand Clinical Trials Registry (ACTRN12617000547347, Registration date: 19/04/2017). |
format | Online Article Text |
id | pubmed-5984798 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-59847982018-06-07 A smartphone application for treating depressive symptoms: study protocol for a randomised controlled trial Deady, M. Johnston, D. A. Glozier, N. Milne, D. Choi, I. Mackinnon, A. Mykletun, A. Calvo, R. A. Gayed, A. Bryant, R. Christensen, H. Harvey, S. B. BMC Psychiatry Study Protocol BACKGROUND: Depression is a commonly occurring disorder linked to diminished role functioning and quality of life. The development of treatments that overcome barriers to accessing treatment remains an important area of clinical research as most people delay or do not receive treatment at an appropriate time. The workplace is an ideal setting to roll-out an intervention, particularly given the substantial psychological benefits associated with remaining in the workforce. Mobile health (mhealth) interventions utilising smartphone applications (apps) offer novel solutions to disseminating evidence based programs, however few apps have undergone rigorous testing. The present study aims to evaluate the effectiveness of a smartphone app designed to treat depressive symptoms in workers. METHODS: The present study is a multicentre randomised controlled trial (RCT), comparing the effectiveness of the intervention to that of an attention control. The primary outcome measured will be reduced depressive symptoms at 3 months. Secondary outcomes such as wellbeing and work performance will also be measured. Employees from a range of industries will be recruited via a mixture of targeted social media advertising and Industry partners. Participants will be included if they present with likely current depression at baseline. Following baseline assessment (administered within the app), participants will be randomised to receive one of two versions of the Headgear application: 1) Intervention (a 30-day mental health intervention focusing on behavioural activation and mindfulness), or 2) attention control app (mood monitoring for 30 days). Participants will be blinded to their allocation. Analyses will be conducted within an intention to treat framework using mixed modelling. DISCUSSION: The results of this trial will provide valuable information about the effectiveness of mhealth interventions in the treatment of depressive symptoms in a workplace context. TRIAL REGISTRATION: The current trial is registered with the Australian and New Zealand Clinical Trials Registry (ACTRN12617000547347, Registration date: 19/04/2017). BioMed Central 2018-06-01 /pmc/articles/PMC5984798/ /pubmed/29859060 http://dx.doi.org/10.1186/s12888-018-1752-5 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Study Protocol Deady, M. Johnston, D. A. Glozier, N. Milne, D. Choi, I. Mackinnon, A. Mykletun, A. Calvo, R. A. Gayed, A. Bryant, R. Christensen, H. Harvey, S. B. A smartphone application for treating depressive symptoms: study protocol for a randomised controlled trial |
title | A smartphone application for treating depressive symptoms: study protocol for a randomised controlled trial |
title_full | A smartphone application for treating depressive symptoms: study protocol for a randomised controlled trial |
title_fullStr | A smartphone application for treating depressive symptoms: study protocol for a randomised controlled trial |
title_full_unstemmed | A smartphone application for treating depressive symptoms: study protocol for a randomised controlled trial |
title_short | A smartphone application for treating depressive symptoms: study protocol for a randomised controlled trial |
title_sort | smartphone application for treating depressive symptoms: study protocol for a randomised controlled trial |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984798/ https://www.ncbi.nlm.nih.gov/pubmed/29859060 http://dx.doi.org/10.1186/s12888-018-1752-5 |
work_keys_str_mv | AT deadym asmartphoneapplicationfortreatingdepressivesymptomsstudyprotocolforarandomisedcontrolledtrial AT johnstonda asmartphoneapplicationfortreatingdepressivesymptomsstudyprotocolforarandomisedcontrolledtrial AT gloziern asmartphoneapplicationfortreatingdepressivesymptomsstudyprotocolforarandomisedcontrolledtrial AT milned asmartphoneapplicationfortreatingdepressivesymptomsstudyprotocolforarandomisedcontrolledtrial AT choii asmartphoneapplicationfortreatingdepressivesymptomsstudyprotocolforarandomisedcontrolledtrial AT mackinnona asmartphoneapplicationfortreatingdepressivesymptomsstudyprotocolforarandomisedcontrolledtrial AT mykletuna asmartphoneapplicationfortreatingdepressivesymptomsstudyprotocolforarandomisedcontrolledtrial AT calvora asmartphoneapplicationfortreatingdepressivesymptomsstudyprotocolforarandomisedcontrolledtrial AT gayeda asmartphoneapplicationfortreatingdepressivesymptomsstudyprotocolforarandomisedcontrolledtrial AT bryantr asmartphoneapplicationfortreatingdepressivesymptomsstudyprotocolforarandomisedcontrolledtrial AT christensenh asmartphoneapplicationfortreatingdepressivesymptomsstudyprotocolforarandomisedcontrolledtrial AT harveysb asmartphoneapplicationfortreatingdepressivesymptomsstudyprotocolforarandomisedcontrolledtrial AT deadym smartphoneapplicationfortreatingdepressivesymptomsstudyprotocolforarandomisedcontrolledtrial AT johnstonda smartphoneapplicationfortreatingdepressivesymptomsstudyprotocolforarandomisedcontrolledtrial AT gloziern smartphoneapplicationfortreatingdepressivesymptomsstudyprotocolforarandomisedcontrolledtrial AT milned smartphoneapplicationfortreatingdepressivesymptomsstudyprotocolforarandomisedcontrolledtrial AT choii smartphoneapplicationfortreatingdepressivesymptomsstudyprotocolforarandomisedcontrolledtrial AT mackinnona smartphoneapplicationfortreatingdepressivesymptomsstudyprotocolforarandomisedcontrolledtrial AT mykletuna smartphoneapplicationfortreatingdepressivesymptomsstudyprotocolforarandomisedcontrolledtrial AT calvora smartphoneapplicationfortreatingdepressivesymptomsstudyprotocolforarandomisedcontrolledtrial AT gayeda smartphoneapplicationfortreatingdepressivesymptomsstudyprotocolforarandomisedcontrolledtrial AT bryantr smartphoneapplicationfortreatingdepressivesymptomsstudyprotocolforarandomisedcontrolledtrial AT christensenh smartphoneapplicationfortreatingdepressivesymptomsstudyprotocolforarandomisedcontrolledtrial AT harveysb smartphoneapplicationfortreatingdepressivesymptomsstudyprotocolforarandomisedcontrolledtrial |